Kemin’s ZeaONE zeaxanthin supplement approved for Brazilian markets

By Adi Menayang contact

- Last updated on GMT

Photo: Pixabay
Photo: Pixabay

Related tags: Kemin, Macular degeneration

Using zeaxanthing collected from marigolds, Kemin’s ZeaONE promises a supplementation that aids the health of the skin and eyes.

Kemin announced that ANVISA, Brazil’s national Health Surveillance Agency, has approved the sale of its product, ZeaONE™ Zeaxanthin. This approval allows Kemin to immediately begin marketing the product in Brazil. “ZeaONE is a dietary free-form zeaxanthin ingredient naturally sourced from marigolds produced by Kemin,” ​the company said in a press release.

Accoridng to Kemin, zeaxanthin, like lutein, is “proven to act as a protective antioxidant and filter of blue light in the eye and skin.” ​Other benefits Kemin said comes from daily zeaxanthin supplementation includes skin health, improvement in visual performance, and a reduction of risk of certain eye conditions.

“The latest findings from the U.S. National Eye Institute’s second age-related eye disease study (AREDS2) reports that 2 mg of zeaxanthin, along with 10mg of FloraGLO Lutein, can slow the progression of age-related macular degeneration,”​ the release said.

The zeaxanthin in ZeaONE comes from a patented line of marigolds exclusively licensed to Kemin and naturally containing the high levels of zeaxanthin (3R, 3’R zeaxanthin) found in the fruits and vegetables in the human diet.

Kemin claimed that its patent-protected marigold seeds were produced with “good agricultural practices [and] tightly controlled supply-chain management.”

ZeaONE is commercially available under DSM’s brand OPTISHARP® Natural.

Related topics: Manufacturers

Related news

Show more

Follow us

Products

View more

Webinars